Fate Therapeutics Inc. buy Piper Sandler
Start price
17.06.24
/
50%
€3.65
Target price
17.06.25
€5.60
Performance (%)
-71.37%
End price
18.06.25
€1.05
Summary
This prediction ended on 18.06.25 with a price of €1.05. The BUY prediction by Piper_Sandler for Fate Therapeutics Inc. performed very badly with a performance of -71.37%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | -2.633% | -2.633% | 20.092% |
| iShares Core DAX® | -3.509% | -8.747% | -0.997% |
| iShares Nasdaq 100 | -2.782% | -0.632% | 14.223% |
| iShares Nikkei 225® | -2.038% | -6.841% | 24.866% |
| iShares S&P 500 | -2.598% | -2.230% | 9.200% |
Comments by Piper_Sandler for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $6.00 price target on the stock, up previously from $4.00.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten